-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617A.O2.6 617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Epigenetic Treatment Approaches

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 2:45 PM-4:15 PM
W110, Level 1 (Orange County Convention Center)
Moderators:
Christopher S. Hourigan, MD PhD, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health and Soheil Meshinchi, MD, PhD, Fred Hutchinson Cancer Research Center

Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Jason H. Mendler, MD, PhD1, Marlene Balys1*, Umayal Sivagnanalingam1*, Allison Eberhardt1*, Korinne Thorne1*, Tzu-Chieh Ho, PhD1*, Mark W. LaMere, BA1*, Samuel Moore1*, Helene McMurray, PhD1*, Jason R. Myers1*, John M. Ashton, PhD1*, Kristen O'Dwyer, MD1*, Jane L. Liesveld, MD2, Laura M. Calvi, MD1 and Michael W. Becker, MD1

1James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
2James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester Medical Center, Rochester, NY

3:00 PM

Terrence Neal Wong, MD PhD1, Jeffery M. Klco, MD/PhD2, Ryan Demeter3*, Christopher A. Miller, PhD4*, Allegra Petti, PhD3*, Nichole Havey5*, Robert Fulton, PhD6*, Sharon Heath7*, Elaine R Mardis, PhD6*, Peter Westervelt, MD, PhD8, John F. DiPersio, MD, PhD9, Matthew J. Walter, MD10, John S. Welch, MD, PhD10, Timothy Graubert, MD11, Richard K Wilson, PhD6*, Timothy J. Ley, MD10 and Daniel C. Link, MD12

1Division of Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO
2St Jude Children's Research Hospital, Memphis, TN
3The McDonnell Genome Institute, Washington University in St. Louis School of Medicine, Saint Louis, MO
4McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO
5Division of Oncology, Washington University in St. Louis School of Medicine, Saint Louis, MO
6Washington University School of Medicine, Saint Louis, MO
7Department of Medicine, Division of Oncology, Washington University in St. Louis, Saint Louis, MO
8Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
9Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
10Division of Oncology, Washington University School of Medicine, St. Louis, MO
11Medicine, Washington University, Saint Louis, MO
12Washington Univ. School of Medicine, Saint Louis, MO

3:15 PM

Emilia L. Lim1*, Diane L. Trinh, MSc1*, Rhonda E. Ries, MA2*, Yussanne Ma, PhD3*, James Topham1*, Maya D. Hughes, MD4*, Erin Pleasance, PhD1*, Andrew J. Mungall, PhD3, Richard Moore, PhD1*, Yongjun Zhao, PhD1*, Daniela S. Gerhard, PhD5*, Vivian Oehler, MD6, E. Anders Kolb, MD7, Alan S. Gamis, MD, MPH8, Malcolm A. Smith, MD, PhD9, Todd A. Alonzo, PhD10, Robert J. Arceci, MD, PhD11, Soheil Meshinchi, MD, PhD2 and Marco A. Marra, PhD1,12

1Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
3Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
4Seattle Children's Hospital, Seattle
5Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
6Fred Hutchinson Cancer Research Ctr., Seattle, WA
7Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
8Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
9Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
10Keck School of Medicine, University of Southern California, Los Angeles, CA
11Ronald A. Matricaria Institute of Molecular Medicine, Phoenix Children's Hospital, Phoenix, AZ
12Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada

3:30 PM

Xiaoyu Qu, PhD1,2*, Megan Othus, PhD1,3*, Jerry Davison, PhD1*, Liying Yan4*, Elihu H. Estey, MD2,5,6*, Jerry Radich, MD1,2,3,7, Harry P. Erba, MD, PhD3,8, Frederick R. Appelbaum, MD1,2,3,7 and Min Fang, MD, PhD1,2,3,7*

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Seattle Cancer Care Alliance, Seattle, WA
3SWOG Leukemia Committee, Portland, OR
4EpigenDx, Inc., Boston, MA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
6Division of Hematology, University of Washington, Seattle, WA
7University of Washington, Seattle, WA
8Internal Medicine, Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL

3:45 PM

John S. Welch, MD, PhD1, Allegra Petti, PhD2*, Christopher A. Miller, PhD3*, Daniel C. Link, MD4, Matthew J. Walter, MD5, Catrina C. Fronick6*, Robert S. Fulton, PhD7*, Lukas D. Wartman, MD8, Geoffrey L. Uy, MD4, Armin Ghobadi, MD9, Michael Tomasson9, Iskra Pusic, MD10, Rizwan Romee, MD10, Todd A Fehniger, MD, PhD10, Keith Stockerl-Goldstein11, Ravi Vij, MBBS9, Stephen Oh, MD PhD12, Camille N. Abboud, MD, FACP10, Amanda F. Cashen, MD8, Mark A. Schroeder, MD10, Meagan A. Jacoby, MD, PhD5, Peter Westervelt, MD, PhD13, John F Dipersio, MD, PhD8, Richard K Wilson, PhD14* and Timothy J. Ley, MD15

1Division of Oncology, Washington University School of Medicine, St. Louis, MO
2Washington University, The Genome Institute, St Louis, MO
3McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO
4Division of Oncology, Washington University School of Medicine, Saint Louis, MO
5Department of Medicine, Division of Oncology, Washington University in St. Louis, Saint Louis, MO
6McDonnell Genome Institute, Washington University in St. Louis, Saint Louis, MO
7McDonnell Genome Institute, Washington University, St Louis, MO
8Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
9Siteman Cancer Center, Washington University, St Louis, MO
10BMT and Leukemia Program, Washington University School of Medicine, Saint Louis, MO
11Washington University School of Medicine, Siteman Cancer Center, Saint Louis, MO
12Division of Hematology, Washington University School of Medicine, St. Louis, MO
13Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
14Washington University School of Medicine, Saint Louis, MO
15Washington University School of Medicine, St. Louis, MO

4:00 PM

Luise Hartmann, MSc1,2,3*, Sebastian Vosberg, MSc1,2,3*, Klaus H. Metzeler, MD1,2,3, Daniela Schumacher2*, Friederike Pastore, MD1,2,3, Kathrin Bräundl1,2,3*, Evelyn Zellmeier2*, Bianka Ksienzyk2*, Nikola P Konstandin, PhD2*, Stephanie Schneider, PhD4*, Stefan Krebs, PhD5*, Alexander Graf, PhD5*, Helmut Blum, PhD5*, Martin Neumann, MD6,7*, Claudia D Baldus, MD6,7, Stefan K. Bohlander, MD8*, Wolfgang Hiddemann, MD2,3,9, Karsten Spiekermann, MD1,2,3 and Philipp A. Greif, MD1,2,3

1German Cancer Consortium (DKTK), Munich, Germany
2Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany
3German Cancer Research Center (DKFZ), Heidelberg, Germany
4Laboratory for Leukemia Diagnostics, Dept. of Internal Medicine III, University Hospital Großhadern, Ludwig-Maximilians-Universität, Munich, Germany
5Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-University, Munich, Germany
6Department of Hematology and Oncology, Charité University Hospital, Berlin, Germany
7German Cancer Consortium (DKTK), Berlin, Germany
8Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
9German Cancer Consortium (DKTK), Heidelberg, Germany

*signifies non-member of ASH